We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current THTX market cap is 69.89M. The company's latest EPS is USD -0.1806 and P/E is -8.42.
| Quarter End | May 2023 | Aug 2023 | Feb 2024 | May 2024 | Aug 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 17.84M | 20.86M | 16.25M | 22.22M | 22.6M |
| Operating Income | -7.65M | 54k | -2.25M | 3.49M | 6.21M |
| Net Income | -10.01M | -746k | -4.48M | 987k | 3.09M |
| Year End November 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 66.05M | 69.82M | 80.06M | 81.76M | 85.87M |
| Operating Income | -17.96M | -25.24M | -39.91M | -10.63M | 8.17M |
| Net Income | -22.67M | -31.73M | -47.24M | -23.96M | -8.31M |
| Quarter End | May 2023 | Aug 2023 | Feb 2024 | May 2024 | Aug 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 68.73M | 56.69M | 72.09M | 70.21M | 69.71M |
| Total Liabilities | 110.26M | 98.39M | 96.69M | 93.42M | 89.39M |
| Total Equity | -41.53M | -41.7M | -24.6M | -23.21M | -19.68M |
| Year End November 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 100.14M | 119.21M | 93.26M | 77.77M | 53.34M |
| Total Liabilities | 96.92M | 101.45M | 115.83M | 98.64M | 78.61M |
| Total Equity | 3.22M | 17.76M | -22.57M | -20.87M | -25.27M |
| Quarter End | May 2023 | Aug 2023 | Feb 2024 | May 2024 | Aug 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.56M | 5.33M | -1.71M | -290k | 4.6M |
| Investing | 734k | 558k | 134k | -137k | 779k |
| Financing | -242k | -7.91M | -275k | -639k | -1.87M |
| Year End November 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -13.55M | -14.48M | -14.69M | -5.68M | 2.38M |
| Investing | 4.78M | -12.45M | 8.68M | 1.11M | 942k |
| Financing | -7.23M | 34.56M | 9.66M | 14.78M | -21.49M |
| Market Cap | 69.89M |
| Price to Earnings Ratio | -8.42 |
| Price to Sales Ratio | 0.81 |
| Price to Cash Ratio | 4.4 |
| Price to Book Ratio | -2.77 |
| Dividend Yield | - |
| Shares Outstanding | 45.98M |
| Average Volume (1 week) | 111.11k |
| Average Volume (1 Month) | 132.58k |
| 52 Week Change | 15.15% |
| 52 Week High | 2.18 |
| 52 Week Low | 1.08 |
| Spread (Intraday) | 0.19 (11.31%) |
| Company Name | Theratechnologies Inc |
| Address |
2015 peel street quebec city, quebec H3A 1T8 |
| Website | https://www.theratech.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
